Novel antibiotics

Staphylococcus aureus is a gram positive bacterium frequently occurring in nature. Over the years a resistant form developed which is known as MRSA – methicillin resistant Staphylococcus aureus. MRSA can cause severe problems especially in immune compromised patients. The antibiotic of choice to treat these infections was vancomycin. But since resistance to vancomycin has also been observed as well as the development of multiple resistances the application of the recently used antibiotics is increasingly limited. Novel active substances are provided. Their application will overcome resistance mechanisms based on genetic variability because they show a different mode of action.

Further information: PDF

ESA Patentverwertungsagentur Sachsen-Anhalt GmbH
Phone: +49 (0)391/8 10 72 20

Contact
Peter Lösler

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.